Cancer Research Technology
Log in Register
Menu

Why was Ximbio created?

Ximbio originates from Cancer Research UK (CRUK) and many of the research reagents in it's portfolio have broad applicability in areas outside of cancer.

The team behind Ximbio has more than 30 years’ experience in commercialising reagents and by rebranding to present the full extent of  Ximbio's capabalities we feel that we can help benefit  the whole life sciences community
 

Ximbio operates as a business unit of CRUK, so has the support of a well established organistion and  the resources to focus on all areas of biology.


Was this information useful? 27 18

see all FAQ's from this category >